Cybersecurity and privacy risk assessment of point-of-care systems in healthcare: A use case approach

EA-2613
Identifiers
3D model (JSmol)
  • InChI=1S/C28H47N2O5P.2HI/c1-22(28(2,3)4)34-36(11,31)35-27-20-24(30(8,9)10)19-26(21-27)33-17-13-16-32-25-15-12-14-23(18-25)29(5,6)7;;/h12,14-15,18-22H,13,16-17H2,1-11H3;2*1H/q+2;;/p-2
    Key: PLSZUOADUSAOET-UHFFFAOYSA-L
  • [I-].[I-].CC(C)(C)C(C)OP(=O)(C)Oc1cc([N+](C)(C)C)cc(c1)OCCCOc2cccc(c2)[N+](C)(C)C
Properties
C28H47I2N2O5P
Molar mass 776.476 g·mol−1
Appearance Solid
Melting point 124–126 °C (255–259 °F; 397–399 K)
Soluble
Solubility Soluble in alcohol, acetone and chloroform
Hazards
Occupational safety and health (OHS/OSH):
Main hazards
Extremely toxic
Lethal dose or concentration (LD, LC):
100 μg/kg (Rats, IV)
12 μg/kg (Rabbits, IV)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

EA-2613 is an extremely toxic organophosphate nerve agent. It's an extremely potent acetylcholinesterase inhibitor that is resistant to atropine and oxime treatment.[1]

See also

References